MDAI
Spectral AI·NASDAQ
--
--(--)
--
--(--)
Spectral AI (MDAI) Company Profile
Spectral Ai, Inc.
A Special Purpose Acquisition Company
Medical instruments
11/17/2020
04/06/2021
NASDAQ Stock Exchange
65
12-31
Common stock
2515 McKinney Avenue, Suite 1000, Dallas, Texas 75201
Provides predictive medical diagnostics.
Spectral AI, Inc., was incorporated in Delaware on November 17, 2020. The company is an artificial intelligence company focused on predictive medical diagnosis. The company is putting a lot of effort into the development of DeepView System, an in-house developed AI-powered MSI device that has FDA BDD status since 2018. The company's DeepView System uses a proprietary AI algorithm to distinguish completely damaged, partially damaged and invisible healthy human tissue features, providing a "Day One" healing potential assessment in seconds. DeepView's output is specially designed to allow doctors to make more accurate, timely and informed decisions about the treatment of patients' wounds.
